Novelties in Locoregional, Systemic and Multimodal Treatment of Primary Malignant Liver Tumors

K. Angelov; S. Stoyanova; E. Yordanov; I. Parvova; N. Khayat; A. Sharkov; A. Zlatarov; T. Dyulgerov

doi:10.2478/amb-2026-0032

.blurhash-client-img { display: none !important; }

Novelties in Locoregional, Systemic and Multimodal Treatment of Primary Malignant Liver Tumors

Acta Medica Bulgarica

Volume 53 (2026): Issue s1 (February 2026)

By: K. Angelov , S. Stoyanova , E. Yordanov , I. Parvova , N. Khayat , A. Sharkov , A. Zlatarov and T. Dyulgerov

Open Access

|Feb 2026

K. Angelov

dr.k.angelov@gmail.com

Department of Surgery, Medical University – Sofia, “Aleksandrovska” University Hospital – Sofia, Bulgaria

S. Stoyanova

Laboratory of Social Pharmacy, Faculty of Chemistry and Pharmacy, Sofia University “Sv. Kliment Ohridski” – Sofia, Bulgaria

E. Yordanov

Laboratory of Social Pharmacy, Faculty of Chemistry and Pharmacy, Sofia University “Sv. Kliment Ohridski” – Sofia, Bulgaria

I. Parvova

Department of Rheumatology, Medical University – Sofia, Bulgaria

N. Khayat

Department of Burns and Plastic Surgery, UMHATEM “N. I. Pirogov” – Sofia, Bulgaria

A. Sharkov

Communication and Audiovisual Production Department, Faculty of Journalism and Mass Communication Sofia University “Sv. Kliment Ohridski” – Sofia, Bulgaria

A. Zlatarov

Department of General and Operative Surgery, Medical University “Prof. Dr. Paraskev Stoyanov” – Varna, Bulgaria

T. Dyulgerov

Department of Psychiatry, “Aleksandrovska” University Hospital, Medical University – Sofia, Bulgaria

Metrics

Articles in this issue

DOI: https://doi.org/10.2478/amb-2026-0032 | Journal eISSN: 2719-5384 | Journal ISSN: 0324-1750

Journal RSS Feed

Language: English

Page range: 206 - 215

Submitted on: Jan 14, 2026

Accepted on: Jan 22, 2026

Published on: Feb 21, 2026

Published by: Medical University - Sofia

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

hepatocellular carcinoma,

intrahepatic cholangiocarcinoma,

surgical treatment,

locoregional treatment,

targeted therapies,

monoclonal antibodies,

tyrosine kinase inhibitors

Related subjects:

Medicine,

Basic medical science,

Immunology,

Clinical medicine,

Clinical medicine, other

© 2026 K. Angelov, S. Stoyanova, E. Yordanov, I. Parvova, N. Khayat, A. Sharkov, A. Zlatarov, T. Dyulgerov, published by Medical University - Sofia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 53 (2026): Issue s1 (February 2026)